Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 7/20 | 0.58 |
| ▸ | LIPG | Q9Y5X9 | 7/20 | 0.58 |
| ▸ | F11 | P03951 | 1/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | MGLL | Q99685 | 1/20 | 0.47 |
| ▸ | IDO1 | P14902 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | CA5A | P35218 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7651263 | 0.80 | LPL (0.61) | LPLLIPGF11CA2CA1 | |
| SCHEMBL13667094 | 0.78 | LPL (0.64) | LPLLIPGF11CA2CA1 | |
| SCHEMBL890400 | 0.78 | LPL (0.73) | LPLLIPGF11CA2CA1 | |
| SCHEMBL204921 | 0.76 | ENPP2 (0.73) | LPLLIPGF11CA2CA1 | |
| SCHEMBL127369 | 0.76 | IDO1 (0.69) | IDO1TSHR | |
| SCHEMBL112402 | 0.76 | LPL (0.61) | LPLLIPGF11CA2CA1 | |
| SCHEMBL23406327 | 0.74 | LPL (0.58) | LPLLIPGF11CA2CA1 | |
| SCHEMBL314531 | 0.74 | LPL (0.58) | LPLLIPGF11CA2CA1 | |
| SCHEMBL150306 | 0.74 | LPL (1.00) | LPLLIPGF11CA2CA1 | |
| SCHEMBL103171 | 0.74 | F11 (0.95) | LPLLIPGF11CA2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674639-A1 | TIRE | Sumitomo Rubber Industries, Ltd. (JP) | 2026-01-07 | — | — | EP | disclosed |
| CN-117362290-A | Compound with anti-tumor activity, preparation method and application thereof | 江苏海洋大学 | 2024-01-09 | — | — | CN | disclosed |
| CN-117203556-A | High refractive index and high birefringence solid organic material | 元平台技术有限公司 | 2023-12-08 | — | — | CN | disclosed |
| CN-111040204-B | Force-induced response dynamic polymer and application thereof | 厦门天策材料科技有限公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-111378165-A | Combined hybrid cross-linked dynamic polymer and application thereof | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| CN-111378168-A | Combined energy absorption method and application thereof | 翁秋梅 | 2020-07-07 | — | — | CN | disclosed |
| CN-108752249-B | Space conjugated organic molecule based on hexaarylbenzene skeleton and preparation and application thereof | 华南理工大学 | 2020-06-19 | — | — | CN | disclosed |
| CN-111171365-A | Force-responsive polymer foam composite material | 翁秋梅 | 2020-05-19 | — | — | CN | disclosed |
| CN-111040204-A | Force-induced response dynamic polymer and application thereof | 翁秋梅 | 2020-04-21 | — | — | CN | disclosed |
| CN-111040203-A | Energy absorption method based on hybrid cross-linked dynamic polymer | 翁秋梅 | 2020-04-21 | — | — | CN | disclosed |
| US-20120245163-A1 | TRPV1 Antagonists | ABBOTT LABORATORIES (US) | 2012-09-27 | — | — | US | disclosed |
| US-20120101103-A1 | 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES | ARRAY BIOPHARMA INC. (US) | 2012-04-26 | — | — | US | disclosed |
| EP-2379535-A1 | 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES | Array Biopharma Inc. (US) | 2011-10-26 | — | — | EP | disclosed |
| WO-2010075200-A1 | 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES | ARRAY BIOPHARMA INC. (US) | 2010-07-01 | — | — | WO | disclosed |
| US-20090042888-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | BLACK LAWRENCE A | 2009-02-12 | — | — | US | disclosed |
| EP-0783486-B1 | NOVEL PROSTAGLANDIN SYNTHASE INHIBITORS | DU PONT PHARM CO (US) | 1999-10-13 | — | — | EP | disclosed |
| US-5932586-A | ANTIINFLAMMATORY AGENTS; ANTIPYRETICS | DUPONT PHARMACEUTICALS COMPANY (US) | 1999-08-03 | — | — | US | disclosed |
| EP-0783486-A1 | NOVEL PROSTAGLANDIN SYNTHASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-07-16 | — | — | EP | disclosed |
| US-5593994-A | ANTIINFLAMMATORY AGENTS | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-01-14 | — | — | US | disclosed |
| WO-1996010012-A1 | NOVEL PROSTAGLANDIN SYNTHASE INHIBITORS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1996-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042888-A1 | Prostaglandin endoperoxide H synthase biosynthesis inhibitors | PTGIS, PTGS1, PTGS2 | LPL 1936/4885LIPG 854/4885F11 2230/4885 |
| US-20120245163-A1 | TRPV1 Antagonists | TRPV1, TRPV3, TRPV6 | LPL 1573/4885LIPG 2316/4885F11 2074/4885 |
| US-20120101103-A1 | 7-PHENOXYCHROMAN CARBOXYLIC ACID DERIVATIVES | PTGDR2, PTGDR, HRH2 | LPL 4738/4885LIPG 4376/4885F11 1324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.